MENU
+Compare
EDAP
Stock ticker: NASDAQ
AS OF
Jun 24, 04:43 PM (EDT)
Price
$1.74
Change
+$0.02 (+1.16%)
Capitalization
281.62M

EDAP EDAP TMS SA Forecast, Technical & Fundamental Analysis

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution... Show more

Industry: #Biotechnology
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EDAP with price predictions
Jun 23, 2025

EDAP sees MACD Histogram crosses below signal line

EDAP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 13, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EDAP as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for EDAP crossed bearishly below the 50-day moving average on May 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where EDAP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDAP advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 204 cases where EDAP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EDAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.581) is normal, around the industry mean (7.892). EDAP's P/E Ratio (100.000) is considerably higher than the industry average of (29.460). EDAP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.521). EDAP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (4.303) is also within normal values, averaging (35.215).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

View a ticker or compare two or three
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDAP is expected to report earnings to fall 15.68% to -16 cents per share on August 20

EDAP TMS SA EDAP Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.06
The last earnings report on May 15 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 5.73K shares outstanding, the current market capitalization sits at 281.62M.
A.I. Advisor
published General Information

General Information

a developer of minimally invasive medical devices for urological diseases

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Parc d'Activites La Poudrette-Lamartine
Phone
+33 472153150
Employees
264
Web
https://www.edap-tms.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABEYX18.930.03
+0.16%
American Beacon International Eq Y
GAAEX5.39N/A
N/A
Guinness Atkinson Alternative Energy
ATEYX160.59N/A
N/A
AB Sustainable Global Thematic Advisor
TIEHX15.44N/A
N/A
Nuveen International Eq I
SVXCX59.09N/A
N/A
Smead International Value C

EDAP and Stocks

Correlation & Price change

A.I.dvisor tells us that EDAP and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
+1.30%
AORT - EDAP
29%
Poorly correlated
+3.18%
AVNS - EDAP
21%
Poorly correlated
-0.25%
SRDX - EDAP
21%
Poorly correlated
N/A
UFPT - EDAP
20%
Poorly correlated
-0.66%
SENS - EDAP
20%
Poorly correlated
-2.86%
More